Search results
31 sie 2015 · AC-T (doxorubicin and cyclophosphamide followed by paclitaxel), also called AC-T and AC-Taxol, is a chemotherapy combination treatment used to treat breast cancer.
11 kwi 2024 · AC is a common, effective, combination chemotherapy treatment commonly used to treat early-stage localized breast cancer; AC contains two chemotherapy agents Adriamycin (doxorubicin) and cyclophosphamide which are usually given together or sequentially with weekly paclitaxel (Taxol) or docetaxel (Taxotere), to create a combination called AC-T ...
1 maj 2018 · Dose-Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) + TH (Taxol® + Herceptin®) is a Chemotherapy Regimen for Breast Cancer - early stage. How does Dose-Dense AC + TH work? Doxorubicin, cyclophosphamide, and paclitaxel are designed to kill or slow the growth of cancer cells.
6 paź 2011 · Among patients with HER2-positive tumors measuring 1 cm or less in the greatest diameter, the estimated 5-year rates of disease-free survival were 86% in the group receiving AC-T plus...
This chemotherapy combination contains the drugs doxorubicin hydrochloride (Adriamycin), cyclophosphamide, and paclitaxel (taxol). Combinations usually work better than single drugs because different drugs kill cancer cells in different ways.
This protocol is part of the AC-TH regimen: 4 cycles of AC, followed by 4 cycles of TH and 13 cycles of trastuzumab. Link to Breast adjuvant AC-TH overview; Link to Breast adjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) three weekly; Drug status: Docetaxel is on the PBS general schedule. Trastuzumab is PBS authority
8 paź 2014 · Based on these studies, TCH, AC-TH, and sequential anthracycline–trastuzumab are standard adjuvant therapy options in this population. Adjuvant chemotherapy is recommended even for small node-negative HER2-breast cancer, but the threshold for treatment is disputed.
